CSS LLC’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-79,519
Closed -$242K 895
2024
Q4
$242K Buy
79,519
+16,240
+26% +$49.4K 0.01% 510
2024
Q3
$328K Buy
+63,279
New +$328K 0.02% 438